Cargando…
Defining Persistent Hotspots: Areas That Fail to Decrease Meaningfully in Prevalence after Multiple Years of Mass Drug Administration with Praziquantel for Control of Schistosomiasis
Preventive chemotherapy with praziquantel for schistosomiasis morbidity control is commonly done by mass drug administration (MDA). MDA regimen is usually based on prevalence in a given area, and effectiveness is evaluated by decreases in prevalence and/or intensity of infection after several years...
Autores principales: | Kittur, Nupur, Binder, Sue, Campbell, Carl H., King, Charles H., Kinung’hi, Safari, Olsen, Annette, Magnussen, Pascal, Colley, Daniel G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Tropical Medicine and Hygiene
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5805060/ https://www.ncbi.nlm.nih.gov/pubmed/29016344 http://dx.doi.org/10.4269/ajtmh.17-0368 |
Ejemplares similares
-
Persistent Hotspots in Schistosomiasis Consortium for Operational Research and Evaluation Studies for Gaining and Sustaining Control of Schistosomiasis after Four Years of Mass Drug Administration of Praziquantel
por: Kittur, Nupur, et al.
Publicado: (2019) -
Environmental Predictors of Schistosomiasis Persistent Hotspots following Mass Treatment with Praziquantel
por: Walker, Joseph W., et al.
Publicado: (2020) -
Discovering, Defining, and Summarizing Persistent Hotspots in SCORE Studies
por: Kittur, Nupur, et al.
Publicado: (2020) -
Effect of Pharmacogenetics Variations on Praziquantel Plasma Concentrations and Schistosomiasis Treatment Outcomes Among Infected School-Aged Children in Tanzania
por: Mnkugwe, Rajabu Hussein, et al.
Publicado: (2021) -
Efficacy and safety of praziquantel and dihydroartemisinin piperaquine combination for treatment and control of intestinal schistosomiasis: A randomized, non-inferiority clinical trial
por: Mnkugwe, Rajabu Hussein, et al.
Publicado: (2020)